PubRank

R W Shaw

Author PubWeight™ 135.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Presenting a routine screening test in antenatal care: practice observed. Public Health 1992 5.34
2 Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990 2.74
3 Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice. BMJ 1994 2.65
4 Cloning, nucleotide sequence, and expression of the Bacillus cereus 5/B/6 beta-lactamase II structural gene. J Bacteriol 1988 2.55
5 The impact of prenatal screening and diagnostic testing upon the cognitions, emotions and behaviour of pregnant women. J Psychosom Res 1989 2.06
6 The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 1997 1.87
7 Medical ethics: a survey of general practitioners' attitudes. J R Coll Gen Pract 1983 1.74
8 Development of a self-administered questionnaire to measure women's knowledge of prenatal screening and diagnostic tests. J Psychosom Res 1988 1.60
9 Membrane permeability of human oocytes in the presence of the cryoprotectant propane-1,2-diol. Fertil Steril 2001 1.53
10 The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn 1992 1.53
11 Screening for Down's syndrome. BMJ 1988 1.48
12 Direct inhibition of ovarian steroidogenesis by cortisol and the modulatory role of 11 beta-hydroxysteroid dehydrogenase. Clin Endocrinol (Oxf) 1993 1.43
13 Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. Br Med J (Clin Res Ed) 1983 1.40
14 Serum levels of pregnancy-associated endometrial alpha 2-globulin (alpha 2-PEG), a glycosylated beta-lactoglobulin homologue, in successful and unsuccessful assisted conception. Hum Reprod 1990 1.39
15 The ultrasound diagnosis and clinical significance of varicocele. Ultrasound Obstet Gynecol 1995 1.36
16 Lack of knowledge in health professionals: a barrier to providing information to patients? Qual Health Care 1994 1.35
17 Clinical associations with objective menstrual blood volume. Eur J Obstet Gynecol Reprod Biol 1999 1.27
18 Factors influencing the uptake of screening for open neural-tube defects and amniocentesis to test for Down's syndrome. Br J Obstet Gynaecol 1989 1.19
19 Variation in response to synthetic luteinizing hormone--releasing hormone (LH-RH) at different phases of the same menstrual cycle in normal women. J Obstet Gynaecol Br Commonw 1974 1.12
20 Evaluation of the risk of pelvic infection following transvaginal oocyte recovery. Hum Reprod 1991 1.09
21 Follicular vascularity--the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme: a preliminary study. Hum Reprod 1997 1.07
22 Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril 1993 1.05
23 The prevalence of endometriosis in women with infertile partners. Eur J Obstet Gynecol Reprod Biol 1993 1.05
24 The use of transvaginal power Doppler ultrasonography to evaluate the relationship between perifollicular vascularity and outcome in in-vitro fertilization treatment cycles. Hum Reprod 1999 1.05
25 Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women. Clin Endocrinol (Oxf) 1988 1.05
26 Studies on the origin of the near-infrared (800-900 nm) absorption of cytochrome c oxidase. Biochim Biophys Acta 1980 1.02
27 Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin. Fertil Steril 1988 1.02
28 Comparative immunohistochemical study of oestrogen and progesterone receptors in the fallopian tube and uterus at different stages of the menstrual cycle and the menopause. Hum Reprod 1994 1.01
29 Responses of the a3 component of cytochrome c oxidase to substrate and ligand addition. Biochim Biophys Acta 1978 1.00
30 Hyperfine structure resolved by 2 to 4 GHz EPR of cytochrome c oxidase. J Biol Chem 1979 1.00
31 Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: a randomized controlled trial. J Psychosom Obstet Gynaecol 1993 1.00
32 Sperm function and structure and seminal plasma prostanoid concentrations in men with IDDM. Diabetes Care 1990 0.99
33 Psychological effects of having amniocentesis: are these due to the procedure, the risk or the behaviour? J Psychosom Res 1992 0.99
34 Morphology and ultrastructure of fallopian tube epithelium at different stages of the menstrual cycle and menopause. Hum Reprod 1994 0.98
35 Effect of training on endoscopic intracorporeal knot tying. Hum Reprod 1997 0.97
36 The oxygen reactions of reduced cytochrome c oxidase. Position of a form with an unusual EPR signal in the sequence of early intermediates. Biochim Biophys Acta 1979 0.96
37 Vitrification of mature mouse oocytes in a 6 M Me2SO solution supplemented with antifreeze glycoproteins: the effect of temperature. Cryobiology 1998 0.96
38 Measurements of the membrane water permeability (Lp) and its temperature dependence (activation energy) in human fresh and failed-to-fertilize oocytes and mouse oocyte. Cryobiology 1992 0.96
39 A novel electron paramagnetic resonance signal of "oxygenated" cytochrome c oxidase. J Biol Chem 1978 0.95
40 Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women. Fertil Steril 1988 0.95
41 Endometriosis, pelvic pain, and psychological functioning. Fertil Steril 1995 0.94
42 Hydrogen ion titration of horse heart ferricytochrome c. Biochemistry 1976 0.94
43 Female pseudohermaphroditism associated with danazol exposure in utero. Case report. Br J Obstet Gynaecol 1984 0.93
44 Ultrasound measurement of endometrial thickness on different ovarian stimulation regimens during in-vitro fertilization. Hum Reprod 1987 0.93
45 The management of predicted ovarian hyperstimulation involving gonadotropin-releasing hormone analog with elective cryopreservation of all pre-embryos. Fertil Steril 1990 0.92
46 On the identity of the high spin heme components of cytochrome c oxidase. Biochim Biophys Acta 1977 0.92
47 Permeability characteristics of human oocytes in the presence of the cryoprotectant dimethylsulphoxide. Hum Reprod 1999 0.91
48 The oestrogen provocation test: a method of assessing the hypothalamic-pituitary axis in patients with amenorrhoea. Clin Endocrinol (Oxf) 1975 0.89
49 Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women. Br Med J (Clin Res Ed) 1987 0.89
50 An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea. Br Med J 1975 0.89
51 Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin. Int J Gynecol Pathol 1995 0.87
52 Perceived risk not actual risk predicts uptake of amniocentesis. Br J Obstet Gynaecol 1991 0.87
53 Developmental potential of murine germinal vesicle stage cumulus-oocyte complexes following exposure to dimethylsulphoxide or cryopreservation: loss of membrane integrity of cumulus cells after thawing. Hum Reprod 2003 0.86
54 Hyponatremic fits in oxytocin-augmented labors. Int J Gynaecol Obstet 1980 0.86
55 Ovarian 11 beta-hydroxysteroid dehydrogenase: potential predictor of conception by in-vitro fertilisation and embryo transfer. Lancet 1993 0.86
56 Vitrification of mouse oocytes using short cryoprotectant exposure: effects of varying exposure times on survival. Mol Reprod Dev 1992 0.86
57 The effect of thyroxine replacement on menstrual blood loss in a hypothyroid patient. Br J Obstet Gynaecol 1992 0.86
58 Sex hormone levels and gonadotrophin release in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1975 0.86
59 Temperature dependence of mature mouse oocyte membrane permeabilities in the presence of cryoprotectant. Cryobiology 1997 0.86
60 Isolated lactase deficiency producing postgastrectomy milk intolerance. Ann Intern Med 1966 0.86
61 Temperature dependence of Kedem-Katchalsky membrane transport coefficients for mature mouse oocytes in the presence of ethylene glycol. Cryobiology 1999 0.86
62 Plasma membrane water permeabilities of human oocytes: the temperature dependence of water movement in individual cells. J Cell Physiol 1992 0.85
63 Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin. Br J Obstet Gynaecol 1989 0.85
64 Twin pregnancy after pituitary desensitisation with LHRH agonist and pure FSH. Lancet 1985 0.85
65 The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis. Bone 1995 0.85
66 A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis. Fertil Steril 1994 0.85
67 Differential effects of cryopreservation on nuclear or cytoplasmic maturation in vitro in immature mouse oocytes from stimulated ovaries. Hum Reprod 1998 0.84
68 Cryopreservation of bovine ovarian tissue: structural normality of follicles after thawing and culture in vitro. Cryobiology 1999 0.83
69 Estrogen modulation of gonadotrophin release. Proc R Soc Med 1975 0.83
70 Proceedings: Sex steroids and gonadotrophin release in the polycystic ovary syndrome. J Obstet Gynaecol Br Commonw 1974 0.83
71 Training obstetricians and midwives to present screening tests: evaluation of two brief interventions. Prenat Diagn 1995 0.83
72 Oxidation of reduced cytochrome c oxidase with 18O2. A search for mu-oxo-bridged metal species in the oxidized enzyme. J Biol Chem 1981 0.83
73 Multiple frequency EPR studies on three forms of oxidized cytochrome c oxidase. Biochim Biophys Acta 1983 0.82
74 Follicular fluid alpha 1-antitrypsin--correlation with fertilizing capacity of oocytes. Br J Obstet Gynaecol 1986 0.82
75 Presentation of endometriosis to general surgeons: a 10 year experience. Br J Surg 1996 0.82
76 Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin Endocrinol (Oxf) 1990 0.82
77 A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. Am J Obstet Gynecol 1993 0.82
78 Dual-mode EPR spectrometry of O2-pulsed cytochrome c oxidase. Biochim Biophys Acta 1984 0.81
79 The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl). Fertil Steril 1996 0.81
80 Trial of scar or elective repeat caesarean section at maternal request? J Obstet Gynaecol 2001 0.81
81 Randomized controlled trial of Syn-Ergel and an active placebo in the treatment of heartburn of pregnancy. J Int Med Res 1978 0.81
82 CA 125 levels in endometriosis patients before, during and after treatment with danazol or LHRH agonists. Eur J Obstet Gynecol Reprod Biol 1989 0.81
83 Buserelin in premenstrual syndrome. Gynecol Endocrinol 1992 0.81
84 The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries. Hum Reprod 1997 0.80
85 Vitrification of human oocytes following minimal exposure to cryoprotectants; initial studies on fertilization and embryonic development. Hum Reprod 1995 0.80
86 Postcaesarean section uterovesical fistula lined by persistent intermediate trophoblast. Am J Surg Pathol 1995 0.80
87 Prosthetic group content and ligand-binding properties of spinach nitrite reductase. J Biol Chem 1987 0.80
88 A comparative morphological and ultrastructural study of endometrial gland and fallopian tube epithelia at different stages of the menstrual cycle and the menopause. Hum Reprod 1994 0.80
89 A simple method for the quantitative determination of serum haptoglobin. J Lab Clin Med 1969 0.80
90 Mullerian mixed tumour of the uterine corpus: a clinical histopathological review of 28 patients. Br J Obstet Gynaecol 1983 0.80
91 A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis. Horm Res 1989 0.79
92 Production, purification and spectral properties of metal-dependent beta-lactamases of Bacillus cereus. Biochim Biophys Acta 1989 0.79
93 Antioxidant enzyme expression, lipid peroxidation, and protein oxidation in human myometrium with parturition. Reprod Sci 2009 0.79
94 Cytochrome c oxidase. Time dependence of optical and EPR spectral changes related to the 'oxygen-pulsed' form. Biochim Biophys Acta 1983 0.79
95 Electron spin echo studies of cytochrome c oxidase. J Biol Chem 1980 0.79
96 Vitrification of mouse oocytes: improved rates of survival, fertilization, and development to blastocysts. Mol Reprod Dev 1991 0.79
97 Slow release intrauterine insemination versus the bolus technique in the treatment of women with cervical mucus hostility. Hum Reprod 1992 0.78
98 Pathological mechanisms to explain some cases of amenorrhoea without organic disease. Br J Obstet Gynaecol 1975 0.78
99 Ovarian electrocautery: responders versus non-responders. Gynecol Endocrinol 1993 0.78
100 Pretreatment with gonadotrophin releasing hormone (GnRH) analogue prior to in vitro fertilisation for patients with endometriosis. Eur J Obstet Gynecol Reprod Biol 1993 0.78
101 LHRH analogues in the treatment of endometriosis--comparative results with other treatments. Baillieres Clin Obstet Gynaecol 1988 0.78
102 Maternal and fetal serum protein concentration in normal pregnancy and pregnancy complicated by proteinuric pre-eclampsia. Am J Obstet Gynecol 1972 0.78
103 Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin-releasing hormone agonist. Fertil Steril 1998 0.78
104 Hormonal changes in patients with polycystic ovarian disease after ovarian electrocautery or pituitary desensitization. Clin Endocrinol (Oxf) 1990 0.78
105 The effect of oestrogen pretreatment on subsequent response to luteinizing hormone releasing hormone in normal women. Clin Endocrinol (Oxf) 1975 0.78
106 Osmotic response of oocytes using a microscope diffusion chamber: a preliminary study comparing murine and human ova. Cryobiology 1988 0.78
107 National survey of the current management of endometriomas in women undergoing assisted reproductive treatment. Hum Reprod 2012 0.77
108 Extended x-ray absorption fine structure of copper in cytochrome c oxidase: Direct evidence for copper-sulfur ligation. Proc Natl Acad Sci U S A 1981 0.77
109 A comparison between the pregnancy outcome of women with gestation diabetes treated with glibenclamide and those treated with insulin. Med J Malaysia 1997 0.77
110 Outcome of in-vitro fertilization and embryo transfer after different regimens of ovarian stimulation. Br J Obstet Gynaecol 1987 0.77
111 A reexamination of the properties of spinach nitrite reductase: protein and siroheme content heterogeneity in purified preparations. Arch Biochem Biophys 1991 0.77
112 Prosthetic group content and ligand binding properties of a spinach catalase. Biochim Biophys Acta 1989 0.77
113 Prevention of ovarian hyperstimulation syndrome. Fertil Steril 1991 0.77
114 Ovarian 11 beta-hydroxysteroid dehydrogenase activity is inversely related to the outcome of in vitro fertilization-embryo transfer treatment cycles. Fertil Steril 1995 0.77
115 Is danazol a useful treatment in unexplained primary infertility? Eur J Obstet Gynecol Reprod Biol 1989 0.77
116 Specific binding of luteinizing hormone releasing hormone to human luteal tissue. Biochem Biophys Res Commun 1983 0.77
117 Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles. Hum Reprod 1992 0.77
118 Use of a superactive luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia. Br J Obstet Gynaecol 1984 0.77
119 Tests of the hypothalamic-pituitary-ovarian axis. Clin Obstet Gynaecol 1976 0.77
120 Effect of maternal age on clinical outcome in women undergoing in vitro fertilization and embryo transfer (IVF-ET). J Med Assoc Thai 1996 0.77
121 The response of patients with polycystic ovarian disease to human menopausal gonadotropin therapy after ovarian electrocautery or a luteinizing hormone-releasing hormone agonist. Fertil Steril 1992 0.77
122 Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose. Hum Reprod 1998 0.77
123 Effect of low-dose prednisolone on sperm fertilizing capacity in subfertile men with circulating antisperm antibodies. Arch Androl 1995 0.77
124 Neuroendocrinology of the menstrual cycle in humans. Clin Endocrinol Metab 1978 0.76
125 Identification of the components of a putative cytochrome bc1 complex in Rhodopseudomonas viridis. Arch Biochem Biophys 1985 0.76
126 Membrane integrity and development of immature murine cumulus-oocyte complexes following slow cooling to -60 degrees C: the effect of immediate rewarming, plunging into LN2 and two-controlled-rate-stage cooling. Cryobiology 2006 0.76
127 Changes in body composition with danazol therapy. Fertil Steril 1991 0.76
128 Adverse effects on sperm movement characteristics in women with minimal and mild endometriosis. Br J Obstet Gynaecol 1993 0.76
129 Is medical management of menorrhagia obsolete? Br J Obstet Gynaecol 1998 0.76
130 Phospholipase activity in the endometrium of women with normal menstrual blood loss and women with proven ovulatory menorrhagia. Br J Obstet Gynaecol 1991 0.76
131 The effects of bromocriptine on the sexual behaviour of hyperprolactinaemic man: a controlled case study. Clin Endocrinol (Oxf) 1984 0.76
132 Mitochondrial myopathy in a primigravid pregnancy. Br J Obstet Gynaecol 1999 0.76
133 The investigation of the hypothalamic-pituitary-ovarian axis. Ir Med J 1977 0.76
134 Pregnancy after orthotopic liver transplantation. Case report. Br J Obstet Gynaecol 1991 0.76
135 Risk-benefit assessment of drugs used for the treatment of menstrual disorders. Drug Saf 1991 0.75
136 Trans-Atlantic in vitro fertilization cold war. Fertil Steril 1991 0.75
137 Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. Br J Obstet Gynaecol 1997 0.75
138 Perifollicular vascularity as a potential variable affecting outcome in stimulated intrauterine insemination treatment cycles: a study using transvaginal power Doppler. Hum Reprod 2001 0.75
139 Treatment of dysfunctional uterine bleeding. Serious complications may occur after hysteroscopic procedures. BMJ 1995 0.75
140 Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol 1989 0.75
141 Long-term outcome by method of delivery of fetuses in breech presentation. External cephalic version at term should be considered. BMJ 1996 0.75
142 Clinical trials in assisted reproduction. Hum Reprod 1992 0.75
143 Successful treatment of infertility using LIPSI with follicular puncture. J R Soc Med 1990 0.75
144 A within-patient comparison between superovulation with intra-uterine artificial insemination using husband's washed spermatozoa and gamete intrafallopian transfer in unexplained infertility. Eur J Obstet Gynecol Reprod Biol 1991 0.75
145 A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis. Fertil Steril 1993 0.75
146 Progress in optimization of transition metal cation chromatography and its application to analysis of silicon wafer contamination. J Chromatogr 1991 0.75
147 A prospective randomized crossover comparison of zygote intrafallopian transfer and in vitro fertilization-embryo transfer in unexplained infertility. J Med Assoc Thai 1994 0.75
148 Effect of an intranasal LHRH agonist on gonadotrophins and hot flushes in post-menopausal women. Maturitas 1985 0.75
149 Successful twin pregnancy despite proven intraperitoneal chlamydial infection at implantation. Br J Obstet Gynaecol 1992 0.75
150 Proceedings: Modulation of gonadotrophin release by steroid hormones in women with hyperprolactinaemia. J Endocrinol 1976 0.75
151 A TRIPLE-SPECTRUM DISCHARGE TUBE. Science 1931 0.75
152 Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens. Clin Reprod Fertil 1986 0.75
153 The effect of progesterone and FSH and LH response to LHRH in normal women. Clin Endocrinol (Oxf) 1975 0.75
154 Exposure to LHRH agonists in early pregnancy following the commencement of mid-luteal buserelin for IVF stimulation. Hum Reprod 1992 0.75
155 Polycystic ovaries: do these represent a specific endocrinopathy? Br J Obstet Gynaecol 1991 0.75
156 Spectroscopic and ligand-binding properties of an oxygen-binding heme protein from Chromatium vinosum. Biochim Biophys Acta 1988 0.75
157 Characterization of the aerosol in the Great Smoky Mountains. Environ Sci Technol 1980 0.75
158 Ambient concentrations of hydrocarbons from conifers in atmospheric gases and aerosol particles measured in Soviet Georgia. Environ Sci Technol 1983 0.75
159 Hormonal management of cycle disturbances. Prog Clin Biol Res 1986 0.75
160 A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with Buserelin for superovulation and in vitro fertilization. Fertil Steril 1988 0.75
161 Effects of cryoprotectants on human oocyte. Lancet 1985 0.75
162 Effect of nafarelin on uterine fibroids measured by ultrasound and magnetic resonance imaging. Eur J Obstet Gynecol Reprod Biol 1990 0.75
163 An unusually aggressive case of endometriosis showing p53 expression. J Clin Pathol 2001 0.75
164 The management of endometriosis: a survey of patients' aspirations. J Obstet Gynaecol 2001 0.75
165 The moderate- and long-range transport of air pollutants and their removal from the atmosphere. Experientia Suppl 1974 0.75
166 A comparison of nafarelin acetate and danazol in the treatment of endometriosis. Fertil Steril 1990 0.75
167 Sex hormone levels and gonadotrophin release in premature ovarian failure. Br J Obstet Gynaecol 1978 0.75
168 Efficacy of an intracervical prostaglandin E2 preparation, Cerviprost, on cervical ripening before first trimester abortion in nulliparous patients. J Obstet Gynaecol (Lahore) 1989 0.75
169 A critical appraisal of assisted reproduction techniques. Hum Reprod 1993 0.75
170 Isolation of cytochrome bc 1 complexes from the photosynthetic bacteria Rhodopseudomonas viridis and Rhodospirillum rubrum. Photosynth Res 1986 0.75
171 The aetiology of galactorrhoea in women with regular menstruation and normal prolactin levels. Hum Reprod 1992 0.75
172 Fertilization and development of the human oocyte following exposure to cryoprotectants, low temperatures and cryopreservation: a comparison of two techniques. Hum Reprod 1991 0.75
173 Studies on oestrogen stimulated neurophysin in women with anovulation. Clin Endocrinol (Oxf) 1981 0.75
174 Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors. Horm Res 1989 0.75
175 Proceedings: Effect of exogenous oestradiol-17beta on subsequent LH-RH responses in amenorrhoeic subjects. Br J Obstet Gynaecol 1976 0.75
176 The control of gonadotrophin release in women with hyperprolactinaemic amenorrhoea: effect of oestrogen and progesterone on the LH and FSH response to LHRH. Clin Endocrinol (Oxf) 1976 0.75
177 Macrocytosis and sulphasalazine treatment of rheumatoid arthritis. Br J Rheumatol 1987 0.75
178 Differential response to LHRH following oestrogen therapy in women with amenorrhoea. Br J Obstet Gynaecol 1979 0.75
179 Proceedings: Hypothalamic-pituitary relationships in the polycystic ovary syndrome: effect of sex steroids on luteinizing hormone releasing hormone responses. J Endocrinol 1975 0.75
180 Stimulation of multiple follicular growth for in vitro fertilization by administration of pulsatile luteinizing hormone-releasing hormone during the midfollicular phase. Fertil Steril 1986 0.75
181 Time-domain observation of optical pulse propagation in whispering-gallery modes of glass spheres. Opt Lett 1998 0.75
182 The influence of number of embryos transferred on pregnancy outcome in women undergoing in vitro fertilization and embryo transfer (IVF-ET). J Med Assoc Thai 1996 0.75
183 AN ADJUSTABLE APPARATUS STAND AND TRUCK. Science 1932 0.75
184 Modification by sex steroids of LHRH response in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1976 0.75
185 Determination of pathophysiological mechanisms in subjects with amenorrhoea and their value in predicting ovulation induction therapy. Clin Reprod Fertil 1982 0.75
186 The use of an enzyme-linked immunosorbent assay for human chorionic gonadotrophin in gynaecological emergencies. Br J Obstet Gynaecol 1986 0.75
187 An attempt to alter the pathophysiology of polycystic ovary syndrome using a gonadotrophin hormone releasing hormone agonist--Nafarelin. Clin Endocrinol (Oxf) 1989 0.75
188 Pathophysiological mechanisms in hypothalamic ovarian failure. Clin Reprod Fertil 1982 0.75
189 Cornual fibroids: a conservative approach to restoring tubal patency using a gonadotropin-releasing hormone agonist (goserelin) with successful pregnancy. Fertil Steril 1989 0.75
190 The effect of cooling and hypertonic exposure on murine oocyte function, fertilization, and development. Cryobiology 1995 0.75
191 Endocrine changes following pituitary desensitization with LHRH agonist and administration of purified FSH to induce follicular maturation. Br J Obstet Gynaecol 1987 0.75
192 Ovary. Clin Endocrinol Metab 1979 0.75
193 Piezoelectric detection of optoacoustic spectra at cryogenic temperatures: neodymium hydroxide below 10 K. Appl Opt 1982 0.75
194 Pressures of acute obstetrics on consultants. Reply from Royal College of Obstetricians and Gynaecologists. BMJ 1999 0.75
195 Effects of chronic luteinizing hormone-releasing hormone agonist treatment on dysfunctional uterine bleeding in the stumptailed macaque. Acta Endocrinol (Copenh) 1984 0.75
196 Oestrogen-gonadotrophin feedback abnormalities in hyperprolactinaemic amenorrhoea demonstrated by the response to clomiphene administration. Br J Obstet Gynaecol 1979 0.75
197 A method for differentiating nonunique estimates of membrane transport properties: mature mouse oocytes exposed to glycerol. Cryobiology 1999 0.75
198 Hypothalmic-pituitary relationships in the polycystic ovary syndrome serum gonadotrophin levels following injection of oestradiol benzoate. Br J Obstet Gynaecol 1975 0.75
199 Assessment of the relevance of zona pellucida antibodies in serum and cervical mucus in patients who have fertilization failure during in vitro fertilization. Fertil Steril 1991 0.75
200 Elective preembryo cryopreservation in ovarian hyperstimulation syndrome. J In Vitro Fert Embryo Transf 1989 0.75
201 Laser applications to chemical and environmental analysis: introduction to the feature issue. Appl Opt 1999 0.75
202 Solvent proton relaxation studies of cytochrome c oxidase solutions. Arch Biochem Biophys 1983 0.75
203 Future environments for Europe: some implications of alternative development paths. Sci Total Environ 1989 0.75
204 The potential effect of controlled ovarian hyperstimulation on follicular vascular perfusion: a study applying power Doppler ultrasonography within a treatment programme using donor sperm. J Obstet Gynaecol 2001 0.75
205 Implications of ultrasonically diagnosed polycystic ovaries. II. Studies of dynamic and pulsatile hormonal patterns. Hum Reprod 1992 0.75
206 IVF pregnancy after induction of an ovulatory endogenous gonadotrophin surge using an LHRH agonist nasal spray. Hum Reprod 1990 0.75
207 AN ADJUSTABLE DOUBLE-SLIT. Science 1931 0.75
208 Proceedings: The oestrogen provocation test'-a means of assessing hypothalamo-pituitary function in amenorrhoea. J Endocrinol 1974 0.75